Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications
Author:
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Publisher
Elsevier BV
Reference53 articles.
1. The ongoing impact of COVID-19 on asthma and pediatric emergency health-seeking behavior in the Bronx, an epicenter;Levene;Am. J. Emerg. Med.,2021
2. Provocation of dry eye disease symptoms during COVID-19 lockdown;Neti;Sci. Rep.,2021
3. Estimated research and development investment needed to bring a new medicine to market, 2009-2018;Wouters;JAMA,2020
4. Advancing drug discovery via artificial intelligence;Chan;Trends Pharmacol. Sci.,2019
5. Drug repurposing approach to fight COVID-19;Singh;Pharmacol. Rep.,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In-silico study of approved drugs as potential inhibitors against 3CLpro and other viral proteins of CoVID-19;PLOS One;2025-06-25
2. An update on knowledge graphs and their current and potential applications in drug discovery;Expert Opinion on Drug Discovery;2025-04-14
3. Knowledge graph applications and multi-relation learning for drug repurposing: A scoping review;Computational Biology and Chemistry;2025-04
4. TarIKGC: A Target Identification Tool Using Semantics-Enhanced Knowledge Graph Completion with Application to CDK2 Inhibitor Discovery;Journal of Medicinal Chemistry;2025-01-02
5. Advanced deep learning approaches enable high-throughput biological and biomedicine data analysis;Methods;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3